Kidney Carcinoma clinical trials
43 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Preop Laxatives in Robotic Urologic Surgery
- NSAID Use After Robotic Partial Nephrectomy
- A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer
- Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Brodalumab in the Treatment of Immune-Related Adverse Events
- [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
- Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- Stereotactic Magnetic Resonance Guided Radiation Therapy
- A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
- A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
- Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
- International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
- Kidney Cancer DNA Registry
- Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
- Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
- Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
- A Study of a Side Effects and Resource Navigation Program for People With Cancer
- Urologic Lymphadenectomy in AMIGO
- Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Liquid Biopsies in Pediatric Solid Tumors
- Integrated Cancer Repository for Cancer Research
- Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Designing Visual Tools to Enhance Cancer Surgeon Decision-making
- Decision Aid (DA) for Renal Patients
- Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
- A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer
- Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
- Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
- Distance-Based Exercise to Preserve Function and Prevent Disability
- Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
- Video Education With Result Dependent dIsclosure
- Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review
- Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy
- Clinical Trial to Treat Stage IV Cancer Patients
- Auriculotherapy in the Treatment of Pre-Operative Anxiety
- Advanced Diffusion Imaging in Renal Cancer Patients
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Kidney Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.